Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 4.96M PLN in the quarter ending June 30, 2026, a decrease of -76.80%. This brings the company's total for the last twelve months to 22.11M, down -75.30% year-over-year. In the year 2025, Ryvu Therapeutics had annual revenue of 87.73M, down -14.03%. That makes Ryvu Therapeutics the 33,453rd largest company in the world by revenue and 281st in Poland.

• Revenue (ttm): 22.11M
• Revenue Growth: -75.30%
• P/S Ratio: 4.50
• Revenue / Employee: 368.15K
• Employees: 228
• Market Cap: 382.87M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• EU Members 61.60M 99.0%
• Other Countries 573.00K 0.9%
• Poland 79.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Ryvu Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.73M	-14.31M	-14.03%
Dec 31, 2024	102.05M	34.05M	50.08%
Dec 31, 2023	67.99M	-2.50M	-3.54%
Dec 31, 2022	70.49M	34.36M	95.08%
Dec 31, 2021	36.13M	-1.19M	-3.20%
Dec 31, 2020	37.33M	3.19M	9.34%
Dec 31, 2019	34.14M	-71.73M	-67.75%
Dec 31, 2017	105.87M	39.15M	58.68%
Dec 31, 2016	66.72M	10.64M	18.98%
Dec 31, 2015	56.08M	14.52M	34.94%
Dec 31, 2014	41.56M	19.64M	89.63%
Dec 31, 2013	21.91M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Sep 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error